Sort by:

select Language:

International Textbook of Leprosy

D.M. Scollard and T.P. Gillis, Eds.: American Leprosy Missions, (2018)

The International Textbook of Leprosy is dedicated to the physicians and health workers caring for their first patient with leprosy, and to all of those in the research community who have encountered some of the fascinating scientific aspects of leprosy and wish to learn more. Read online at:

Fièvre de Lassa : Introduction. Cours

World Health Organization WHO, (2018)

La fièvre de Lassa est une fièvre hémorragique virale aiguë d'une durée d'une à quatre semaines qui sévit en Afrique occidentale. La fièvre de Lassa, une fièvre hémorragique virale avec des symptômes similaires à ceux de la maladie virale d'Ebola, est endémique dans une grande partie de l'Afrique de l'Ouest et provoque généralement une poussée saisonnière de Platform: OpenWHO

A guide for surveillance of antimicrobial resistance in leprosy: 2017 update

E. A. Cooreman, Eds.: WHO SEARO/Department of Control of Neglected Tropical Diseases, (2017)

In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of infections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone

Major Infectious Diseases. Disease Control Priorities, Third Edition : Volume 6

Holmes, King K.; Bertozzi, Stefano; Bloom, Barry R.; Jha, Prabhat, Eds.: World Bank, (2017)

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings. Large File: 136 MB!!!!! Please download from the website link!

Vacina da dengue: qual é a recomendação?

ANVISA Agência Nacional de Vigilância Sanitária , (2017)

Bula da vacina foi atualizada com nova recomendação para vacina da dengue da Sanofi Aventis para pessoas nunca infectadas pela dengue.

184 hits